Sunitinib malate (SU11248) shows antitumour activity in patients with metastatic renal cell carcinoma: Updated results from phase II trials Meeting Abstract


Authors: Motzer, R.; Rini, B.; Michaelson, M.; Redman, B.; Hudes, G.; Wilding, I.; Bukowski, R.; George, D.; Kim, S.; Baum, C.
Abstract Title: Sunitinib malate (SU11248) shows antitumour activity in patients with metastatic renal cell carcinoma: Updated results from phase II trials
Meeting Title: 13th European Cancer Conference (ECCO 13)
Journal Title: EJC Supplements
Volume: 3
Issue: 2
Meeting Dates: 2005 Oct 30-Nov 3
Meeting Location: Paris, France
ISSN: 1359-6349
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2005-10-01
Start Page: 227
Language: English
ACCESSION: WOS:000247564800774
PROVIDER: wos
DOI: 10.1016/S1359-6349(05)81092-4
Notes: --- - Meeting Abstract: 797 - S - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer